Genetic modifiers predisposing to congenital heart disease in the sensitized down syndrome population

Circulation: Cardiovascular Genetics

Volumn 5, Issue 3, 2012, Pages 301-308

  Li, Huiqing ^a   Cherry, Sheila ^a   Klinedinst, Donna ^a   DeLeon, Valerie ^a   Redig, Jennifer ^b   Reshey, Benjamin ^b   Chin, Michael T ^c   Sherman, Stephanie L ^d   Maslen, Cheryl L ^b   Reeves, Roger H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Congenital heart disease; Down syndrome; Genetic modifier

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATRIOVENTRICULAR SEPTAL DEFECT; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CRELD1 GENE; DNA DETERMINATION; DNA MODIFICATION; DOWN SYNDROME; FEMALE; GENE; GENETIC PREDISPOSITION; HEY2 GENE; HUMAN; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ALLELES; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL ADHESION MOLECULES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN SYNDROME; EXTRACELLULAR MATRIX PROTEINS; GENOTYPE; HEART DEFECTS, CONGENITAL; HUMANS; MICE; MICE, KNOCKOUT; MUTATION; REPRESSOR PROTEINS; TRISOMY;

MUS;

EID: 84864624061     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.111.960872     Document Type: Article

References (36)

1. Ferencz C, Boughman JA, Neill CA, Brenner JI, Perry LW. Congenital cardiovascular malformations: questions on inheritance. Baltimore- Washington Infant Study Group. J Am Coll Cardiol. 1989;14:756-763.
2. Maslen CL, Babcock D, Robinson SW, Bean LJ, Dooley KJ, Willour VL, Sherman SL. CRELD1 mutations contribute to the occurrence of cardiac atrioventricular septal defects in down syndrome. Am J Med Genet A. 2006;140:2501-2505.
3. Korbel JO, Tirosh-Wagner T, Urban AE, Chen XN, Kasowski M, Dai L, Grubert F, Erdman C, Gao MC, Lange K, Sobel EM, Barlow GM, Aylsworth AS, Carpenter NJ, Clark RD, Cohen MY, Doran E, Falik- Zaccai T, Lewin SO, Lott IT, McGillivray BC, Moeschler JB, Pettenati MJ, Pueschel SM, Rao KW, Shaffer LG, Shohat M, Van Riper AJ, Warburton D, Weissman S, Gerstein MB, Snyder M, Korenberg JR. The genetic architecture of Down syndrome phenotypes revealed by highresolution analysis of human segmental trisomies. Proc Natl Acad Sci U S A. 2009;106:12031-12036.
4. Korenberg JR, Bradley C, Disteche CM. Down syndrome: molecular mapping of the congenital heart disease and duodenal stenosis. Am J Hum Genet. 1992;50:294-302.
5. Delabar JM, Theophile D, Rahmani Z, Chettouh Z, Blouin JL, Prieut M, Noel B, Sinet PM. Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur J Hum Genet. 1993;1:114-124.
6. Rupp PA, Fouad GT, Egelston CA, Reifsteck CA, Olson SB, Knosp WM, Glanville RW, Thornburg KL, Robinson SW, Maslen CL. Identification, genomic organization and mRNA expression of CRELD1, the founding member of a unique family of matricellular proteins. Gene. 2002;293:47-57.
7. Robinson SW, Morris CD, Goldmuntz E, Reller MD, Jones MA, Steiner RD, Maslen CL. Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects. Am J Hum Genet. 2003;72: 1047-1052.
8. Maslen CL. Molecular genetics of atrioventricular septal defects. Curr Opin Cardiol. 2004;19:205-210.
9. Reamon-Buettner SM, Borlak J. Hey2 mutations in malformed hearts. Hum Mutat. 2006;27:118.
10. Wang B, Zhou S, Chen Q, Xie X, Huang G, Wang J, Zhoua S, Ma X. Hairy-related transcription factor 2 is not potentially related to congenital heart disease in Chinese patients. Int J Cardiol. 2011;146:415-416.
11. Donovan J, Kordylewska A, Jan YN, Utset MF. Tetralogy of fallot and other congenital heart defects in Hey2 mutant mice. Curr Biol. 2002;12: 1605-1610.
12. Gessler M, Knobeloch KP, Helisch A, Amann K, Schumacher N, Rohde E, Fischer A, Leimeister C. Mouse gridlock: No aortic coarctation or deficiency, but fatal cardiac defects in Hey2-/- mice. Curr Biol. 2002;12:1601-1604.
13. Moore CS, Roper RJ. The power of comparative and developmental studies for mouse models of down syndrome. Mamm Genome. 2007;18: 431-443.
14. Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS, Schmidt C, Bronson RT, Davisson MT. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet. 1995;11:177-184.
15. Williams AD, Mjaatvedt CH, Moore CS. Characterization of the cardiac phenotype in neonatal ts65dn mice. Dev Dyn. 2008;237:426-435.
16. Sakata Y, Kamei CN, Nakagami H, Bronson R, Liao JK, Chin MT. Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2. Proc Natl Acad Sci U S A. 2002;99: 16197-16202.
17. Lorenzi H, Duvall N, Cherry SM, Reeves RH, Roper RJ. PCR prescreen for genotyping the ts65dn mouse model of down syndrome. Biotechniques. 2010;48:35-37.
18. Moore CS, Lee JS, Birren B, Stetten G, Baxter LL, Reeves RH. Integration of cytogenetic with recombinational and physical maps of mouse chromosome 16. Genomics. 1999;59:1-5.
19. Fischer A, Klamt B, Schumacher N, Glaeser C, Hansmann I, Fenge H, Gessler M. Phenotypic variability in Hey2-/- mice and absence of HEY2 mutations in patients with congenital heart defects or Alagille syndrome. Mamm Genome. 2004;15:711-716.
20. Sakata Y, Koibuchi N, Xiang F, Youngblood JM, Kamei CN, Chin MT. The spectrum of cardiovascular anomalies in CHF1/Hey2 deficient mice reveals roles in endocardial cushion, myocardial and vascular maturation. J Mol Cell Cardiol. 2006;40:267-273.
21. Fischer A, Gessler M. Hey genes in cardiovascular development. Trends Cardiovasc Med. 2003;13:221-226.
22. Leimeister C, Externbrink A, Klamt B, Gessler M. Hey genes: a novel subfamily of hairy- and enhancer of split related genes specifically expressed during mouse embryogenesis. Mech Dev. 1999;85:173-177.
23. Bruneau BG, Nemer G, Schmitt JP, Charron F, Robitaille L, Caron S, Conner DA, Gessler M, Nemer M, Seidman CE, Seidman JG. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell. 2001;106:709-721.
24. Winston JB, Erlich JM, Green CA, Aluko A, Kaiser KA, Takematsu M, Barlow RS, Sureka AO, LaPage MJ, Janss LL, Jay PY. Heterogeneity of genetic modifiers ensures normal cardiac development. Circulation. 2010;121:1313-1321.
25. Guo Y, Shen J, Yuan L, Li F, Wang J, Sun K. Novel CRELD1 gene mutations in patients with atrioventricular septal defect. World J Pediatr. 2010;6:348-352.
26. Sarkozy A, Esposito G, Conti E, Digilio MC, Marino B, Calabro R, Pizzuti A, Dallapiccola B. CRELD1 and GATA4 gene analysis in patients with nonsyndromic atrioventricular canal defects. Am J Med Genet A. 2005;139:236-238.
27. Zatyka M, Priestley M, Ladusans EJ, Fryer AE, Mason J, Latif F, Maher ER. Analysis of CRELD1 as a candidate 3p25 atrioventicular septal defect locus (AVSD2). Clin Genet. 2005;67:526-528.
28. Kusuma L, Dinesh SM, Savitha MR, Krishnamurthy B, Narayanappa D, Ramachandra NB. A maiden report on CRELD1 single-nucleotide polymorphism association in congenital heart disease patients of Mysore, South India. Genet Test Mol Biomarkers. 2011;15:483-487.
29. Posch MG, Perrot A, Schmitt K, Mittelhaus S, Esenwein EM, Stiller B, Geier C, Dietz R, Gessner R, Ozcelik C, Berger F. Mutations in GATA4, NKX2.5, CRELD1, and BMP4 are infrequently found in patients with congenital cardiac septal defects. Am J Med Genet A. 2008;146A: 251-253.
30. Sago H, Carlson EJ, Smith DJ, Kilbridge J, Rubin EM, Mobley WC, Epstein CJ, Huang TT. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc Natl Acad Sci U S A. 1998;95:6256-6261.
31. Olson LE, Richtsmeier JT, Leszl J, Reeves RH. A chromosome 21 critical region does not cause specific Down syndrome phenotypes. Science. 2004;306:687-690.
32. Pereira PL, Magnol L, Sahun I, Brault V, Duchon A, Prandini P, Gruart A, Bizot JC, Chadefaux-Vekemans B, Deutsch S, Trovero F. A new mouse model for the trisomy of the Abcg1-u2af1 region reveals the complexity of the combinatorial genetic code of Down syndrome. Hum Mol Genet. 2009;18:4756-4769.
33. Yu T, Li Z, Jia Z, Clapcote SJ, Liu C, Li S, Asrar S, Pao A, Chen R, Fan N, Carattini-Rivera S, Bechard AR, Spring S, Henkelman RM. A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions. Hum Mol Genet. 2010;19:2780-2791.
34. Eiraku M, Tohgo A, Ono K, Kaneko M, Fujishima K, Hirano T, Kengaku M. DNER acts as a neuron-specific Notch ligand during Bergmann glial development. Nat Neurosci. 2005;8:873-880.
35. Baladron V, Ruiz-Hidalgo MJ, Nueda ML, Diaz-Guerra MJ, Garcia- Ramirez JJ, Bonvini E, Gubina E, Laborda J. Dlk acts as a negative regulator of Notch1 activation through interactions with specific EGF-like repeats. Exp Cell Res. 2005;303:343-359.
36. Lindsell CE, Shawber CJ, Boulter J, Weinmaster G. Jagged: a mammalian ligand that activates Notch1. Cell. 1995;80:909-917.